GLG News by Medical Device Experts

The market for MRSA screening continues to develop as companies launch new, improved techologies to meet laboratory needs.  The CDC estimates that 94,000 patients are infected with MRAS each year, resulting in approximately 19,000 deaths.  Recent media focus on MRSA infections, both in acute...

New developments in lung cancer may help diagnose a disease which is responsible for over 156,000 deaths per year in the United States.  Rosetta Genomics (ROSG) selected real time PCR from Roche Diagnostics (ROG.VX) and Nanogen's (NGEN) MGB probe technology for 3 new tests expected to be launched...

A new study published in the Journal of the American Medical Association estimated a lower risk of developing breast cancer by the age of 70 in women carrying mutations in one of two genes (BRAC1 and BRAC2).  This comes at the same time as Myriad Genetics (MYGN) is marketing their BRAC1/BRAC2...

Agendia announced the completion of a clinical study demonstrating the value of its Mamaprint(R) breast cancer prognosis test in postmenopausal women.  Agendia believes that this data will enable it to file for expanded claims with the FDA for Mamaprint(R).  Expanded claims for Agendia's DNA...

    Product shelf-life is a major economic concern for the agricultural industry.   The biological mechanism for regulating the ripening of fruits is mediated by ethylene.     Ethylene  management is addressed in three ways: 1) Ethylene...

This is a very significant event for Ceregene.  Previous studies, with drug treatment, on treatment for parkinsons have shown that the placebo effect only lasts for three months.  The symptoms of Parkinson's  increase 5-10% per year( as part of the natural progression of the disorder). ...

Lowering cost of Botox is key, but not enough to induce patients to undergo Botox treatments.

Genetic screening for disease states, cancer, cancer progression and other metabolic conditions often promise much, but fail to deliver the clinical sensitivity and specificity of traditional diagnostic tests.  The relatively low predictive value and nominal regulation of...

A new rapid test for chlamydia trachoma, the world's most prevalent sexually transmitted bacterial disease will improve the efficiency of existing screening programs and make testing accessible to developing countries that often do not have the healthcare infrastructure to support diagnosis and treatment....

For too long Allergan has monopolized the therapeutic and cosmetic market of botulinum toxin type A, and has taken full advantage of that monopoly by raising the price of Botox almost biannually. Reloxin studies are very favorable when compared to Botox, and may even surpass it in one or two aspects....